-
-
-
-
-
-
-
Macrogenics (MGNX) Reports In-Line Q1 EPS
-
-
-
-
-
-
-
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Macrogenics (MGNX) Achieves $100M in Milestones Related to Retifanlimab Collaboration with Incyte
-
-
-
-
-
-
-
After-hours movers: Alphabet, Levi, Paramount Global and more
-
-
-
-
-
-
-
Macrogenics (MGNX) Tops Q2 EPS, Revenues Miss
-
-
-
-
-
-
-
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
-
-
-
-
-
-
-
MacroGenics Provides Update on Corporate Progress and Second Quarter 2022 Financial Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

